학술논문

Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections
Document Type
Clinical report
Source
Clinical Ophthalmology. June 30, 2023, Vol. 17, p1683, 8 p.
Subject
Diabetic retinopathy -- Research
Medical research
Medicine, Experimental
Medical centers -- Research
Glaucoma -- Research
Vascular endothelial growth factor -- Research
Macular degeneration -- Research
Language
English
ISSN
1177-5483
Abstract
Purpose: To study the effects of intravitreal injection (IVI) of anti-VEGF (vascular endothelial growth factor) agents on intraocular pressure (IOP) and find associations with acute pressure spikes. Methods: This was a three-month, prospective study of patients receiving outpatient IVI of anti-VEGF agents for diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) at the Acuity Eye Group Medical Centers. IOP was measured pre- and post-injection at 10-minute intervals up to 50 minutes after injection with a handheld tonometer. Patients with an IOP greater than 35 mmHg at 30 minutes received an anterior chamber paracentesis (ACP), while patients below 35 mmHg were monitored without intervention. Results: A total of 617 patients (51% female, 49% male) received IVI for DR (n = 199), AMD (n = 355), and RVO (n = 63). ACP was performed in 17 patients. Average pre-injection IOP was 16 [+ or -] 4 compared to 24 [+ or -] 7 mmHg for the non-ACP vs ACP group, respectively (mean [+ or -] standard deviation), p < 0.0001. IOP returned to baseline in 98% of patients at 50 minutes. A diagnosis of glaucoma and glaucoma suspect was more prevalent in the ACP group compared to the non-ACP group, 82.3% vs 14.2% and 17.6% vs 9.0%, respectively, p < 0.0001 and p > 0.05. Patients with a pre-injection IOP >25 mmHg and a history of glaucoma had a 58.3% rate of ACP. A 31-gauge needle had a higher mean increase in IOP from baseline compared to 30-gauge needle, p < 0.0001. Conclusion: IOP spikes are most significant in the first 10 minutes after IVI but typically resolve within the first hour. However, utilizing a smaller 31-gauge IVI in patients with a glaucoma history and pre- injection IOP >25 mmHg may be associated with significant IOP spikes lasting longer than 30 minutes. Keywords: intravitreal injection, anti-VEGF, glaucoma, acute pressure spikes, anterior chamber paracentesis
Introduction Macular edema secondary to retinal vein occlusion, diabetic retinopathy, and age-related macular degeneration are some of the most common causes of visual impairment and blindness worldwide. (1) Vascular endothelial [...]